Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6410)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2022 (publication date) through May 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alshammari E, Zhang YX, Yang Z. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. World J Gastroenterol 2022; 28(29): 3753-3766 [PMID: 36157542 DOI: 10.3748/wjg.v28.i29.3753] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6220/full/v28/i29/3753.htm |
| Number | Citing Articles |
| 1 |
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
|
| 2 |
Kun Xia, Yaoxiang Zhou, Youping Xie, Yinzhong Cai. Role of SMYD2 in gastrointestinal cancer progression (Review). Oncology Letters 2025; 29(6): 1 doi: 10.3892/ol.2025.15028
|
| 3 |
Jiale Li, Qiqiang Zhang, Chunyan Wang, Shupeng Liu. Eltrombopag Inhibited Liver Cancer by Enhancing SMYD4 Protein Degradationvia TRIP12 Ubiquitinase. Advanced Therapeutics 2025; 8(2) doi: 10.1002/adtp.202400372
|